SDGR

What one share of Schrodinger holds

Pharmaceutical Preparations

Our differentiated, physics-based computational platform enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at a lower cost, compared to traditional methods.

Schrodinger’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$3.50
Profit−$0.73
Capex (buildings and equipment)$0.05
Free cash flow−$1.76
Cash and investments$5.54
Book value$4.40

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2019$14.25−$4.09$0.31−$4.65—−$15.25
2020$1.80−$0.41$0.04$0.24—$10.28
2021$1.95−$1.42$0.10−$1.10—$9.01
2022$2.54−$2.10$0.11−$1.79—$7.21
2023$2.89$0.54$0.18−$2.00—$8.71
2024$2.86−$2.58$0.10−$2.27—$5.80
2025$3.48−$1.41$0.02$0.17—$4.96

Common questions about Schrodinger

How much does one share of Schrodinger earn?

Over the last 12 months, Schrodinger lost $0.73 for each share on $3.50 of sales.

Does Schrodinger pay a dividend?

Schrodinger didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Schrodinger’s book value per share?

Schrodinger’s book value is $4.40 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Schrodinger have?

Each share of Schrodinger has $5.54 of cash and investments, as of June 30, 2026.

What is Schrodinger’s free cash flow per share?

−$1.76 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

Has Schrodinger bought back shares?

Schrodinger’s share count rose about 1123% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.